Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition

• Published in: The FASEB journal 2012-07, Vol.26 (7), p.3021-3031
• Main Authors: Renga, Barbara, Mencarelli, Andrea, D'Amore, Claudio, Cipriani, Sabrina, Baldelli, Franco, Zampella, Angela, Distrutti, Eleonora, Fiorucci, Stefano
• Format: Article
• Language: English
• Subjects: Animals; Chenodeoxycholic Acid - analogs & derivatives; Chenodeoxycholic Acid - metabolism; Chenodeoxycholic Acid - pharmacology; Fasting - metabolism; G6Pase; Gluconeogenesis - genetics; Gluconeogenesis - physiology; Glucose-6-Phosphatase - metabolism; Hep G2 Cells; Hepatocytes - metabolism; Humans; Ligands; Liver - drug effects; Liver - metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; nuclear receptors; PEPCK; Phosphoenolpyruvate Carboxykinase (ATP) - metabolism; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear - agonists; Receptors, Cytoplasmic and Nuclear - deficiency; Receptors, Cytoplasmic and Nuclear - genetics; Receptors, Cytoplasmic and Nuclear - metabolism; Receptors, Glucocorticoid - antagonists & inhibitors; Receptors, Glucocorticoid - genetics; Receptors, Glucocorticoid - metabolism; RNA, Small Interfering - genetics; SHP; Signal Transduction
• ISSN: 0892-6638; 1530-6860
• DOI: 10.1096/fj.11-195701

ABSTRACT The glucocorticoid receptor (GR) is a master gene orchestrating the activation of gluconeogenic genes in the liver in response to food withdrawal. Mechanisms of GR regulation by other nuclear receptors, however, are poorly defined. Here, we report that the farnesoid X receptor (FXR), a bile acid sensor, activates gluconeogenic pathways in the liver and regulates GR expression and activity. FXR‐null mice are hypoglycemic in the unfed state and exhibit both a reduced hepatic production of glucose in response to the pyruvate challenge and a decreased expression of two rate‐limiting enzymes involved in gluconeogenesis, phosphoenolpyruvate carboxykinase (PEPCK), and glucose‐6‐phosphatase (G6Pase), along with blunted liver expression of GR. Treating wild‐type mice with a semisynthetic FXR ligand (6E‐CDCA) increases the liver expression of GR, PEPCK, and G6Pase. This effect was lost in fed animals, as well as in FXR–/– mice. The human and mouse GR promoters contain a conserved FXR‐responsive element (an ER‐8 sequence) whose activation by FXR ligation leads to GR transcription. GR silencing by siRNA in vitro or its pharmacological antagonism in vivo with mifepristone reverses the effect of FXR activation on expression of gluconeogenic genes. These findings demonstrate that an FXR‐GR pathway regulates the activation of hepatic gluconeogenesis in the transition from the unfed to the fed state.—Renga, B., Mencarelli, A., D'Amore, C., Cipriani, S., Baldelli, F., Zampella, A., Distrutti, E., Fiorucci, S. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. FASEB J. 26, 3021–3031 (2012). www.fasebj.org